Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High-Dose Intravenous Steroid Treatment Seems to Have No Long-Term Negative Effect on Bone Mineral Density of Young and Newly Diagnosed Multiple Sclerosis Patients: A Pilot Study.
Simeakis G, Anagnostouli M, Fakas N, Koutsikos J, Papatheodorou A, Chanopoulos K, Athanasiou K, Papatheodorou G, Zapanti E, Alevizaki M, Kaltsas G, Terpos E. Simeakis G, et al. Among authors: anagnostouli m. Biomedicines. 2023 Feb 17;11(2):603. doi: 10.3390/biomedicines11020603. Biomedicines. 2023. PMID: 36831140 Free PMC article.
IgG4-related autoimmune manifestations in Alemtuzumab-treated multiple sclerosis patients.
Vakrakou AG, Tzanetakos D, Evangelopoulos ME, Fragoulis GE, Kazakou P, Lekka E, Kafasi N, Tzartos JS, Andreadou E, Koutsis G, Gialafos E, Dimitrakopoulos A, Zampeli E, Rontogianni D, Theocharis S, Zapanti E, Stathopoulos PA, Anagnostouli M, Stefanis L, Kilidireas C. Vakrakou AG, et al. Among authors: anagnostouli m. J Neuroimmunol. 2021 Dec 15;361:577759. doi: 10.1016/j.jneuroim.2021.577759. Epub 2021 Oct 29. J Neuroimmunol. 2021. PMID: 34742035
Multiple Sclerosis and MEN2 Neoplasia in a Female Patient: A Unique Co-Existence with Expanded Immunological Interest and Therapeutical Challenges, before and after Patient's COVID-19 Infection.
Markoglou N, Simeakis G, Alevizaki M, Velonakis G, Chatzistamatiou T, Spyropoulou-Vlachou M, Stavropoulos-Giokas C, Stefanis L, Anagnostouli M. Markoglou N, et al. Among authors: anagnostouli m. Biomedicines. 2022 Nov 8;10(11):2850. doi: 10.3390/biomedicines10112850. Biomedicines. 2022. PMID: 36359367 Free PMC article.
Structural MRI correlates of cognitive function in multiple sclerosis.
Artemiadis A, Anagnostouli M, Zalonis I, Chairopoulos K, Triantafyllou N. Artemiadis A, et al. Among authors: anagnostouli m. Mult Scler Relat Disord. 2018 Apr;21:1-8. doi: 10.1016/j.msard.2018.02.003. Epub 2018 Feb 6. Mult Scler Relat Disord. 2018. PMID: 29438835
A case of Alemtuzumab-induced neutropenia in multiple sclerosis in association with the expansion of large granular lymphocytes.
Vakrakou AG, Tzanetakos D, Valsami S, Grigoriou E, Psarra K, Tzartos J, Anagnostouli M, Andreadou E, Evangelopoulos ME, Koutsis G, Chrysovitsanou C, Gialafos E, Dimitrakopoulos A, Stefanis L, Kilidireas C. Vakrakou AG, et al. Among authors: anagnostouli m. BMC Neurol. 2018 Oct 29;18(1):178. doi: 10.1186/s12883-018-1183-4. BMC Neurol. 2018. PMID: 30373566 Free PMC article.
The role of melatonin in Multiple Sclerosis.
Skarlis C, Anagnostouli M. Skarlis C, et al. Among authors: anagnostouli m. Neurol Sci. 2020 Apr;41(4):769-781. doi: 10.1007/s10072-019-04137-2. Epub 2019 Dec 16. Neurol Sci. 2020. PMID: 31845043 Review.
HLA-DRB1 allele impact on pediatric multiple sclerosis in a Hellenic cohort.
Gontika M, Skarlis C, Artemiadis A, Pons R, Mastroyianni S, Vartzelis G, Theodorou V, Kilindireas K, Stefanis L, Dalakas M, Chrousos G, Anagnostouli M. Gontika M, et al. Among authors: anagnostouli m. Mult Scler J Exp Transl Clin. 2020 Feb 24;6(1):2055217320908046. doi: 10.1177/2055217320908046. eCollection 2020 Jan-Mar. Mult Scler J Exp Transl Clin. 2020. PMID: 32133149 Free PMC article.
80 results